Page 62 - MI-1-2

Microbes & Immunity A disruptive solution for endometriosis

pain. Front Pain Res (Lausanne). 2024;5:1402918. 184(11):2807-2824.
doi: 10.3389/fpain.2024.1402918 doi: 10.1016/j.cell.2021.04.041
114. Napadow V, Edwards RR, Cahalan CM, et al. Evoked pain 118. Martinelli S, Nannini G, Cianchi F, Staderini F, Coratti F,
analgesia in chronic pelvic pain patients using respiratory- Amedei A. Microbiota transplant and gynecological
gated auricular vagal afferent nerve stimulation. Pain Med. disorders: The bridge between present and future treatments.
2012;13(6):777-789. Microorganisms. 2023;11(10):2407.
doi: 10.1111/j.1526-4637.2012.01385.x doi: 10.3390/microorganisms11102407
115. Dobson GP, Letson HL, Morris JL. Revolution in sepsis: 119. Guidozzi F. Endometriosis-associated cancer. Climacteric.
A symptoms-based to a systems-based approach? J Biomed 2021;24(6):587-592.
Sci. 2024;31(1):57.
doi: 10.1080/13697137.2021.1948994
doi: 10.1186/s12929-024-01043-4
120. Arab C, Vanderlei LCM, Da Silva Paiva L, et al. Cardiac
116. Burla L, Kalaitzopoulos DR, Metzler JM, Scheiner D, autonomic modulation impairments in advanced breast
Imesch P. Popularity of endocrine endometriosis drugs and cancer patients. Clin Res Cardiol. 2018;107(10):924-936.
limited alternatives in the present and foreseeable future:
A survey among 1420 affected women. Eur J Obstet Gynecol doi: 10.1007/s00392-018-1264-9
Reprod Biol. 2021;262:232-238. 121. Chen LH, Lo WC, Huang HY, Wu HM. A lifelong impact
doi: 10.1016/j.ejogrb.2021.05.040 on endometriosis: Pathophysiology and pharmacological
treatment. Int J Mol Sci. 2023;24(8):7503.
117. Saunders PTK, Horne AW. Endometriosis: Etiology,
pathobiology, and therapeutic prospects. Cell. 2021; doi: 10.3390/ijms24087503

Volume 1 Issue 2 (2024) 56 doi: 10.36922/mi.4389